The Long Run with Luke Timmerman
Ep195: Ken Song on T-cell Engagers for Autoimmune Diseases
Dienstag, 3. März 2026 · 1 h 06
Kapitelklicken springt direkt hin
Shownotes
Ken Song, CEO of San Diego-based Candid Therapeutics, on developing bispecific T-cell engaging antibodies for autoimmune disease.
